Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus placebo after bariatric surgery for poor weight loss
2017-002407-10Phase 4Completed
- Sponsor
- University College London
- Start
- Jan 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Liraglutide arm with Placebo arm (2 arms). Primary endpoint: Percentage weight loss at 24 weeks. Started Jan 2018; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2017-002407-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002407-10.